Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation.

Calligaris D, Feldman DR, Norton I, Olubiyi O, Changelian AN, Machaidze R, Vestal ML, Laws ER, Dunn IF, Santagata S, Agar NY.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9978-83. doi: 10.1073/pnas.1423101112. Epub 2015 Jul 27.

2.

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.

Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG.

Oncotarget. 2015 Apr 20;6(11):8788-806.

3.

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.

Du Z, Abedalthagafi M, Aizer AA, McHenry AR, Sun HH, Bray MA, Viramontes O, Machaidze R, Brastianos PK, Reardon DA, Dunn IF, Freeman GJ, Ligon KL, Carpenter AE, Alexander BM, Agar NY, Rodig SJ, Bradshaw EM, Santagata S.

Oncotarget. 2015 Mar 10;6(7):4704-16.

4.

Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging.

Platt S, Nduom E, Kent M, Freeman C, Machaidze R, Kaluzova M, Wang L, Mao H, Hadjipanayis CG.

Clin Neurosurg. 2012;59:107-13. No abstract available.

5.

EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H.

Cancer Res. 2010 Aug 1;70(15):6303-12. doi: 10.1158/0008-5472.CAN-10-1022. Epub 2010 Jul 20.

Supplemental Content

Loading ...
Support Center